Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on 13 and 14 August, 2025.
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences has informed the stock exchanges that its management will participate in the Avendus Spark INDX-Asia Conference scheduled for August 13 and 14, 2025, in Singapore. The meetings will be held in one-on-one and/or group formats with analysts and institutional investors. The company has clarified that no new presentation will be made and no unpublished price-sensitive information will be discussed during these meetings. The schedule may change due to last-minute exigencies on either side.
This is a routine investor engagement disclosure with no new business or financial information being shared, so it is unlikely to have a direct impact on the stock price. However, participation in a foreign broker conference signals the company's ongoing efforts to expand institutional investor outreach, which can support long-term interest in the stock.